Betancur César, Martínez Yordan, Merino-Guzman Ruben, Hernandez-Velasco Xochitl, Castillo Rogel, Rodríguez Roman, Tellez-Isaias Guillermo
Departamento de Ciencias Pecuarias, Facultad de Medicina Veterinaria y Zootecnia, Universidad de Córdoba, Montería 230002, Colombia.
Science and Agricultural Production Department, Zamorano University, Francisco Morazán P.O. Box 93, Honduras.
Animals (Basel). 2020 Jul 17;10(7):1218. doi: 10.3390/ani10071218.
The objective was to evaluate the effect of oral administration of CAM6 strain as an alternative to antibiotics in weaned pigs on productive parameters, blood biochemical profile, and IgA serum levels. Thirty-six 21-day-old weaned piglets were randomly assigned to three groups with three replicates of four piglets each. Treatments consisted of a basal diet (BD; T0) without probiotics or antibiotics; BD + antibiotics and the same basal diet used in T0 plus oral administration of 5 mL × 10 CFU/mL of CAM-6 (T2). During the study (21 to 49 days of age) T2 obtained a similar live weight, weight gain, and feed conversion ratio when compared to the T1. Both treatments were better in these variables compared to T0 ( ≤ 0.05). Furthermore, T2 increased serum IgA levels ( ≤ 0.05). Additionally, hematological parameters and acid-base balance remained similar in all groups. However, significant reductions in the mean corpuscular hemoglobin concentration, platelets, and metabolic hydrogen ions were observed in T1 ( ≤ 0.05). The results of this study suggest that supplementation with CAM6 can be an alternative to antibiotics. Studies to evaluate its efficacy under commercial conditions and water administration require further evaluation.
目的是评估口服CAM6菌株作为断奶仔猪抗生素替代品对生产性能参数、血液生化指标和血清IgA水平的影响。36头21日龄断奶仔猪被随机分为三组,每组四个重复,每个重复四头仔猪。处理包括不含益生菌或抗生素的基础日粮(BD;T0);BD+抗生素以及与T0相同的基础日粮加口服5 mL×10 CFU/mL的CAM-6(T2)。在研究期间(21至49日龄),与T1相比,T2的活重、体重增加和饲料转化率相似。与T0相比,这两种处理在这些变量上均表现更好(P≤0.05)。此外,T2提高了血清IgA水平(P≤0.05)。此外,所有组的血液学参数和酸碱平衡保持相似。然而,T1组的平均红细胞血红蛋白浓度、血小板和代谢氢离子显著降低(P≤0.05)。本研究结果表明,补充CAM6可作为抗生素的替代品。评估其在商业条件下的疗效以及通过饮水给药的研究需要进一步评估。